Use of the SAMe-TT2R2 score to predict good anticoagulation control with warfarin in Chinese patients with atrial fibrillation: Relationship to ischemic stroke incidence

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Chan, Pak Hei ^a   Hai, Jo Jo ^a   Chan, Esther W ^a   Li, Wen Hua ^a,b   Tse, Hung Fat ^a   Wong, Ian C K ^a   Lip, Gregory Y H ^c   Siu, Chung Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULATION; ARTICLE; ASSESSMENT OF HUMANS; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHINESE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SAME TT2R2 SCORE; SENSITIVITY AND SPECIFICITY; COMPLICATION; INTRACRANIAL HEMORRHAGES; RISK FACTOR; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; WARFARIN;

EID: 84962090115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150674     Document Type: Article

References (20)

1. Hart RG, Pearce LA, Aguilar MI. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Annals of internal medicine. 2007;147(8):590-2. Epub 2007/10/17. PMID: 17938402.
2. Lau KK, Chan PH, Yiu KH, Chan YH, Liu S, Chan KH, et al. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke. Cardiology journal. 2014. doi: 10.5603/CJ.a2014.0034 PMID: 24846512.
3. Siu CW, Tse HF. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation. Circulation Arrhythmia and electrophysiology. 2014;7(2):300-6. doi: 10.1161/CIRCEP.113.000858 PMID: 24610776.
4. Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, et al. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control. Stroke. 2015;46(1):23-30. Epub 2014/11/20. doi: 10.1161/strokeaha.114.006476 PMID: 25406148.
5. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. Journal of thrombosis and thrombolysis. 2003;15(3):213-6. doi: 10.1023/B:THRO.0000011377.78585.63 PMID: 14739631.
6. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circulation Cardiovascular quality and outcomes. 2008;1(2):84-91. Epub 2009/12/25. doi: 10.1161/circoutcomes.108. 796185 PMID: 20031794.
7. Gallego P, Roldan V, Marin F, Romera M, Valdes M, Vicente V, et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thrombosis and haemostasis. 2013;110(6):1189-98. Epub 2013/10/08. doi: 10.1160/th13-07-0556 PMID: 24096615.
8. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thrombosis and haemostasis. 2013;110(6):1087-107. Epub 2013/11/15. doi: 10.1160/th13-06-0443 PMID: 24226379.
9. European Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European heart journal. 2010;31(19):2369-429. Epub 2010/08/31. doi: 10.1093/eurheartj/ehq278 PMID: 20802247.
10. Chiang CE, Wang KL, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thrombosis and haemostasis. 2014;111(5):789-97. Epub 2014/02/07. doi: 10.1160/th13-11-0948 PMID: 24500243.
11. Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT (2) R (2) score. Chest. 2013;144(5):1555-63. Epub 2013/05/15. doi: 10.1378/chest.13-0054 PMID: 23669885.
12. Nuhrich J, Steven D, Berner I, Rostock T, Hoffmann B, Servatius H, et al. Impact of Biatrial Defragmentation in Patients with Paroxysmal Atrial Fibrillation: Results from A Randomized Prospective Study. Heart rhythm: the official journal of the Heart Rhythm Society. 2014. Epub 2014/06/08. doi: 10.1016/j. hrthm.2014.06.002 PMID: 24907643.
13. Huang D, Anguo L, Yue WS, Yin L, Tse HF, Siu CW. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2-VASc score of 1. Pacing and clinical electrophysiology: PACE. 2014;37(11):1442-7. doi: 10.1111/pace.12445 PMID: 25039724.
14. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-72. Epub 2009/09/19. doi: 10.1378/chest.09-1584 PMID: 19762550.
15. Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-100. Epub 2010/03/20. doi: 10.1378/chest.10-0134 PMID: 20299623.
16. Rosendaal FR, Cannegieter SC, Van Der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-9. Epub 1993/03/01. PMID: 8470047.
17. Azoulay L, Dell'Aniello S, Simon TA, Renoux C, Suissa S. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. European heart journal. 2014;35(28):1881-7. doi: 10. 1093/eurheartj/eht499 PMID: 24353282.
18. Clarkesmith DE, Pattison HM, Lip GY, Lane DA. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PloS one. 2013;8(9):e74037. doi: 10. 1371/journal.pone.0074037 PMID: 24040156; PubMed Central PMCID: PMC3767671.
19. Lip GY, Haguenoer K, Saint-Etienne C, Fauchier L. Relationship of the SAMe-TT2R2score to poor quality anticoagulation, stroke, clinically relevant bleeding and mortality in patients with atrial fibrillation. Chest. 2014. Epub 2014/04/12. doi: 10.1378/chest.13-2976 PMID: 24722973.
20. Poli D, Antonucci E, Testa S, Lip GY. A prospective validation of the SAMe-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin. Internal and emergency medicine. 2014;9(4):443-7. Epub 2014/03/22. doi: 10.1007/s11739-014-1065-8 PMID: 24652166.